N4 Pharma plc (N4P.L) Diversifiers

Equity · Currency in GBp · Last updated Jun 5, 2026

N4 Pharma plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma plc was incorporated in 1979 and is based in London, the United Kingdom.

Looking to balance out your exposure to N4P.L? The ETFs below have the lowest correlation with N4P.L — they tend to move on their own, which can help reduce risk when N4P.L drops. The stock ideas table highlights individual companies that behave independently from N4P.L.

No Diversifiers Found for N4P.L

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements N4P.L

Add N4P.L to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with N4P.L